Skip to content

MAZEMAZE THERAPEUTICS INC

CUSIP 578784100 · common stock

1 tracked investor held MAZE THERAPEUTICS INC (MAZE) at the end of Q3 2026, worth $17.3M. The largest holder was Adar1 Capital Management, with 0.7% of its portfolio.

Holders · Q3 2026
1
New holders
0
Value held
$17.3M
Quarter-end price (est.)
$27.18

Investors holding MAZE · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.74%637,353$17.3MADD+87.9%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026100$17.3M$27.18
Q2 2026100$10.1M$29.84
Q1 2026100$1.5M$29.85
Q4 2025100$7.4M$41.43